Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-20-043010

Chief Scientific Officer sold 33,300 shares at an average $39.58 ($1,317,980)

  • Chief Scientific Officer acquired 33,300 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-07-16 Option exercise +22,200 $6.32 $140,304 22,879 D: show line 1 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-07-16 Sale −14,820 $39.39 $583,760 8,059 D: show line 2 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-07-16 Sale −7,380 $39.92 $294,610 679 D: show line 3 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-07-17 Option exercise +11,100 $6.32 $70,152 11,779 D: show line 4 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-07-17 Sale −1,200 $38.61 $46,332 10,579 D: show line 5 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-07-17 Sale −8,194 $39.62 $324,646 2,385 D: show line 6 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-07-17 Sale −1,706 $40.23 $68,632 679 D: show line 7 in the form
Open-market sales · 33,300 sh · avg $39.58 · $1,317,980

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
ROBINS HARLAN S Chief Scientific Officer 2020-07-16 Option exercise · Stock Option (Right to Buy) −22,200 378,000 D: show line 8 in the form
ROBINS HARLAN S Chief Scientific Officer 2020-07-17 Option exercise · Stock Option (Right to Buy) −11,100 366,900 D: show line 9 in the form
Loading xslF345X03/doc4.xml…